Atenolol vs Nonatenolol β-Blockers for the Treatment of Hypertension: A Meta-analysis
Conclusions In the young, both atenolol and nonatenolol β-blockers are effective in reducing cardiovascular end points for hypertension without compelling indications. Atenolol is associated with increased stroke in the elderly but whether this extends to nonatenolol β-blockers remains uncertain.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Atenolol | Cardiology | Cardiovascular | Clinical Trials | Databases & Libraries | Heart | Heart Attack | Hypertension | Statistics | Stroke